Cargando…

Cancer stem cell-derived extracellular vesicles preferentially target MHC-II–macrophages and PD1+ T cells in the tumor microenvironment

Immunotherapy is an approved treatment option for head and neck squamous cell carcinoma (HNSCC). However, the response rate to immune checkpoint blockade is only 13% for recurrent HNSCC, highlighting the urgent need to better understand tumor-immune interplay, with the ultimate goal of improving pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Callejo, Patricia, Guo, Zihan, Ziglari, Tahereh, Claudio, Natalie Marcia, Nguyen, Kayla Hoang, Oshimori, Naoki, Seras-Franzoso, Joaquim, Pucci, Ferdinando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897575/ https://www.ncbi.nlm.nih.gov/pubmed/36735677 http://dx.doi.org/10.1371/journal.pone.0279400

Ejemplares similares

Gene Expression Profiling of Lymph Node Sub-Capsular Sinus Macrophages in Cancer
por: Pellin, Danilo, et al.
Publicado: (2021)

Cancer stem cells and their niche in the progression of squamous cell carcinoma
por: Oshimori, Naoki
Publicado: (2020)

Preferential interaction of MHC class I with TAPBPR in the absence of glycosylation
por: Neerincx, Andreas, et al.
Publicado: (2019)

Contribution of Particle-Induced Lysosomal Membrane Hyperpolarization to Lysosomal Membrane Permeabilization
por: Ziglari, Tahereh, et al.
Publicado: (2021)

Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells
por: Gener, Petra, et al.
Publicado: (2018)

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste
por: Unzueta, Ugutz, et al.
Publicado: (2022)

Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II+ Cells Is Due to Preferential Transduction of Dendritic Cells In Vivo
por: Ciré, Séverine, et al.
Publicado: (2014)

Preferential differentiation of T cell receptor specificities based on the MHC glycoproteins encountered during development. Evidence for positive selection
Publicado: (1989)

Isolation of cell-free bacterial inclusion bodies
por: Rodríguez-Carmona, Escarlata, et al.
Publicado: (2010)

Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
por: Khaja, Azharuddin Sajid Syed, et al.
Publicado: (2017)

Polymorphic sites preferentially avoid co-evolving residues in MHC class I proteins
por: Dib, Linda, et al.
Publicado: (2018)

ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival
por: Van Duzer, Avery, et al.
Publicado: (2019)

Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
por: Cano-Garrido, Olivia, et al.
Publicado: (2015)

Extracellular Vesicles as Drug Delivery Systems in Cancer
por: Hernandez-Oller, Laia, et al.
Publicado: (2020)

Understanding TR Binding to pMHC Complexes: How Does a TR Scan Many pMHC Complexes yet Preferentially Bind to One
por: Khan, Javed Mohammed, et al.
Publicado: (2011)

Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression
por: Han, Guangchun, et al.
Publicado: (2022)

Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells
por: Tu, Jingyao, et al.
Publicado: (2022)

Intrathymic presentation of circulating non-MHC antigens by medullary dendritic cells. An antigen-dependent microenvironment for T cell differentiation
Publicado: (1986)

PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma
por: Lee, Yunqin, et al.
Publicado: (2014)

MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment
por: Griffith, Brian D., et al.
Publicado: (2022)

PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
por: Šmahel, Michal
Publicado: (2017)

Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1(-) stem cell-like T cells over PD-1(+) T cells curbing tumor progression
por: del Rio, Maria-Luisa, et al.
Publicado: (2023)

NK cell education via nonclassical MHC and non-MHC ligands
por: He, Yuke, et al.
Publicado: (2017)

Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment
por: Acúrcio, Rita C., et al.
Publicado: (2022)

An impediment to random walk: trehalose microenvironment drives preferential endocytic uptake of plasmonic nanoparticles
por: Siddhanta, Soumik, et al.
Publicado: (2016)

γ-Herpesvirus Latency Is Preferentially Maintained in Splenic Germinal Center and Memory B Cells
por: Flaño, Emilio, et al.
Publicado: (2002)

MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway
por: Wilson, Kayla R., et al.
Publicado: (2018)

Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer
por: Aust, Stefanie, et al.
Publicado: (2017)

PD-L1 and MHC-I expression in 19 human tumor cell lines and modulation by interferon-gamma treatment
por: Grenga, Italia, et al.
Publicado: (2014)

Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
por: Torrealba, Débora, et al.
Publicado: (2016)

Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
por: Ulldemolins, Anna, et al.
Publicado: (2021)

Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells
por: Montero, Sara, et al.
Publicado: (2020)

Preferentially expressed genes in stomach adenocarcinoma cells.
por: Shiosaka, T., et al.
Publicado: (1987)

Cambogin Is Preferentially Cytotoxic to Cells Expressing PDGFR
por: Tian, Ze, et al.
Publicado: (2011)

Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
por: Cámara-Sánchez, Patricia, et al.
Publicado: (2022)

MHC-independent αβT cells: Lessons learned about thymic selection and MHC-restriction
por: Van Laethem, François, et al.
Publicado: (2022)

Antigen Presentation by MHC-Dressed Cells
por: Nakayama, Masafumi
Publicado: (2015)

Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
por: Villaverde, Antonio, et al.
Publicado: (2012)

Epitopes associated with MHC restriction site of T cells. III. I-J epitope on MHC-restricted T helper cells
Publicado: (1987)

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance
por: Deng, Yalan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o1o0ic16gda2d7cbad6lnk1roo